Birdwatch Note
2023-07-08 15:20:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This treatment is stated in the study as a potential treatment with ongoing clinical trials and has not been proven effective. “Treatment benefit is predicted to be maximal at 16 mg/day... A placebo-controlled trial… is now ongoing to confirm efficacy at this dose.” https://pubmed.ncbi.nlm.nih.gov/31658058/
Written by 93146EA33FC230C8F5CB223C6C035E27F592589094ACA41AFDC5C22C7439ED21
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1677542277462507520
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1677699305740566530
- noteId - 1677699305740566530
- participantId -
- noteAuthorParticipantId - 93146EA33FC230C8F5CB223C6C035E27F592589094ACA41AFDC5C22C7439ED21 Participant Details
- createdAtMillis - 1688829659293
- tweetId - 1677542277462507520
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This treatment is stated in the study as a potential treatment with ongoing clinical trials and has not been proven effective. “Treatment benefit is predicted to be maximal at 16 mg/day... A placebo-controlled trial… is now ongoing to confirm efficacy at this dose.” https://pubmed.ncbi.nlm.nih.gov/31658058/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-07-08 15:20:59 UTC (1688829659293) |
2023-07-09 17:10:50 UTC (1688922650332) |
CURRENTLY_RATED_HELPFUL | 2023-07-09 17:10:50 UTC (1688922650332) |
CURRENTLY_RATED_HELPFUL | 2023-07-09 17:10:50 UTC (1688922650332) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-07-08 18:52:50 -0500 | Rating Details | |
2023-07-08 17:25:34 -0500 | Rating Details | |
2023-07-08 17:20:37 -0500 | Rating Details | |
2023-07-08 17:00:39 -0500 | Rating Details | |
2023-07-08 16:54:03 -0500 | Rating Details | |
2023-07-08 16:41:32 -0500 | Rating Details | |
2023-07-08 16:34:54 -0500 | Rating Details | |
2023-07-08 16:18:42 -0500 | Rating Details | |
2023-07-08 16:06:04 -0500 | Rating Details | |
2023-07-08 16:04:28 -0500 | Rating Details | |
2023-07-08 16:02:30 -0500 | Rating Details | |
2023-07-08 15:58:08 -0500 | Rating Details | |
2023-07-08 14:47:05 -0500 | Rating Details | |
2023-07-08 13:49:36 -0500 | Rating Details | |
2023-07-08 13:41:27 -0500 | Rating Details | |
2023-07-08 13:14:30 -0500 | Rating Details | |
2023-07-08 13:08:37 -0500 | Rating Details | |
2023-07-08 12:57:17 -0500 | Rating Details | |
2023-07-08 12:56:05 -0500 | Rating Details | |
2023-07-08 12:48:21 -0500 | Rating Details | |
2023-07-08 12:16:30 -0500 | Rating Details | |
2023-07-08 12:05:22 -0500 | Rating Details | |
2023-07-08 11:51:03 -0500 | Rating Details | |
2023-07-08 11:33:55 -0500 | Rating Details | |
2023-07-08 10:40:05 -0500 | Rating Details | |
2023-07-09 13:03:18 -0500 | Rating Details | |
2023-07-09 12:17:25 -0500 | Rating Details | |
2023-07-09 11:41:29 -0500 | Rating Details | |
2023-07-09 11:00:45 -0500 | Rating Details | |
2023-07-09 10:31:29 -0500 | Rating Details | |
2023-07-09 07:35:25 -0500 | Rating Details | |
2023-07-09 07:24:04 -0500 | Rating Details | |
2023-07-09 06:58:07 -0500 | Rating Details | |
2023-07-09 03:37:25 -0500 | Rating Details | |
2023-07-09 02:18:21 -0500 | Rating Details | |
2023-07-09 00:08:36 -0500 | Rating Details | |
2023-07-08 21:24:26 -0500 | Rating Details | |
2023-07-08 21:17:27 -0500 | Rating Details | |
2023-07-08 20:47:57 -0500 | Rating Details | |
2023-07-08 20:41:39 -0500 | Rating Details | |
2023-07-08 20:11:53 -0500 | Rating Details | |
2023-07-08 20:08:12 -0500 | Rating Details | |
2023-07-08 19:59:46 -0500 | Rating Details | |
2023-07-08 19:57:36 -0500 | Rating Details | |
2023-07-08 19:38:04 -0500 | Rating Details | |
2023-07-10 19:25:50 -0500 | Rating Details | |
2023-07-10 18:48:10 -0500 | Rating Details | |
2023-07-10 17:54:56 -0500 | Rating Details | |
2023-07-10 17:54:23 -0500 | Rating Details | |
2023-07-10 17:54:15 -0500 | Rating Details | |
2023-07-10 17:53:15 -0500 | Rating Details | |
2023-07-10 17:46:09 -0500 | Rating Details | |
2023-07-10 07:00:11 -0500 | Rating Details | |
2023-07-11 00:16:18 -0500 | Rating Details | |
2023-07-10 19:48:16 -0500 | Rating Details | |
2023-07-10 18:53:57 -0500 | Rating Details | |
2023-07-10 17:51:47 -0500 | Rating Details | |
2023-07-21 11:30:30 -0500 | Rating Details |